PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1572465
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1572465
The Global AI-based Surgical Robots Market was valued at USD 5.7 billion in 2023. Projections indicate a robust growth trajectory, with an anticipated CAGR of 16.2% from 2024 to 2032. This surge can be largely attributed to technological advancements, an uptick in surgical procedures, and supportive government initiatives and funding, among other factors.
Minimally invasive procedures, known for being less traumatic and promoting quicker recovery, are increasingly adopting AI-based surgical robots. These robots provide enhanced control and precision, crucial for such surgeries. For instance, Meritas Health reports that the U.S. sees over 15 million laparoscopic surgeries annually. Moreover, AI-based surgical robots enhance precision, mitigating human error risks. This leads to superior patient outcomes, reduced complication rates, and shorter hospital stays.
The infusion of AI into robotic surgeries is revolutionizing surgical practices, enhancing their efficiency, safety, and effectiveness. AI integration facilitates delicate maneuvers, minimizing tissue damage, shortening recovery times, and boosting patient outcomes. By streamlining operations, AI not only cuts down surgery durations but also allows for a greater number of procedures in the same timeframe. This efficiency is vital in high-demand surgical environments, enhancing operational throughput and curbing healthcare costs. Furthermore, AI-driven predictive analytics and simulation tools bolster preoperative planning. By enabling surgeons to visualize diverse scenarios and outcomes, these tools prepare them for intricate surgeries, reducing intraoperative surprises and elevating surgical results.
The AI-based surgical robots industry is classified based on type, application, end-use, and region.
In 2023, the hardware segment led the revenue share, valued at USD 3.5 billion. Advanced imaging systems, including 3D imaging, intraoperative imaging, and real-time visualization tools, are pivotal for guiding AI-based surgical procedures. As the demand for these high-performance imaging systems surges, healthcare providers are increasingly adopting cutting-edge hardware technologies. This encompasses advanced robotic arms, precision instruments, and AI-integrated imaging systems, all aimed at elevating care quality.
In 2023, hospitals commanded a dominant market share of 73.9%. Specialized surgical services in hospitals, such as neurosurgery, cardiovascular surgery, and oncology, find immense value in AI-based surgical robots. These robots are instrumental in executing intricate surgeries that demand precision and real-time decision-making. Furthermore, as hospitals seek scalable and adaptable surgical solutions, the modular and customizable nature of AI-based surgical robots becomes a significant draw, especially for those aiming to broaden their surgical capabilities.
North America AI-based surgical robots market held a revenue of USD 3.8 billion in 2023. Projections suggest a CAGR of 14.9% from 2024 to 2032. The region witnesses a consistent rise in surgical procedures, fueled by an aging demographic, increased elective surgeries, and evolving surgical techniques. To cater to this surging demand, AI-based surgical robots are finding a prominent place, especially in high-volume surgical centers. Additionally, the regulatory landscape in North America favors the adoption of AI surgical technologies. U.S. regulatory bodies, notably the FDA, offer streamlined approval pathways for medical devices, including AI-powered surgical robots, expediting their market entry.